Overview

Open Label Arimidex in Gynecomastia

Status:
Completed

Trial end date:
2006-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety, effectiveness, pharmacokinetics and pharmacodynamics of anastrozole (ARIMIDEX™) in the treatment of boys with gynecomastia.

Phase:

Phase 2

Details

Lead Sponsor:

AstraZeneca

Treatments:

Anastrozole